UK trial will see if data trumps hype over ivermectin’s role in COVIDDespite limited data, anti-parasitic drug ivermectin has become widely used in some areas of the world as a Share XUK trial will see if data trumps hype over ivermectin’s role in COVIDhttps://pharmaphorum.com/news/uk-trial-will-see-if-data-trumps-hype-over-ivermectins-role-in-covid/
Digital strategies for pharma’s physician engagementPharmaceutical sales and marketing operations have been forced to follow a steep learning curve as they adjust to Share XDigital strategies for pharma’s physician engagementhttps://pharmaphorum.com/views-analysis-sales-marketing/digital-strategies-for-pharmas-physician-engagement/
Pair of R&D updates bolster GSK ahead of investor meetingGlaxoSmithKline (GSK) has reported encouraging data for its COVID-19 antibody sotrovimab, and an alliance with Halozyme to develop Share XPair of R&D updates bolster GSK ahead of investor meetinghttps://pharmaphorum.com/news/pair-of-rd-updates-bolster-gsk-ahead-of-investor-meeting/
US aims $80m of its rescue plan funding at public health ITPresident Joe Biden’s $3 billion pandemic rescue package includes $80 million in funding for to strengthen the US’s Share XUS aims $80m of its rescue plan funding at public health IThttps://pharmaphorum.com/news/us-aims-80m-of-its-rescue-plan-funding-at-public-health-it/
NHS app downloads spike after COVID jab status updateThe NHS App has soared in popularity since it was updated in May to allow people to record Share XNHS app downloads spike after COVID jab status updatehttps://pharmaphorum.com/news/nhs-app-downloads-spike-after-covid-jab-status-update/
EU and AZ both claim victory in COVID jab supply lawsuitA court in Belgium has ordered AstraZeneca to deliver additional doses of its COVID-19 vaccine to EU member Share XEU and AZ both claim victory in COVID jab supply lawsuithttps://pharmaphorum.com/news/eu-and-az-both-claim-victory-in-covid-jab-supply-lawsuit/
White House pledges $3 billion war chest for COVID antiviralsThe Biden Administration has said it will allocate $3 billion of its pandemic rescue plan to the development Share XWhite House pledges $3 billion war chest for COVID antiviralshttps://pharmaphorum.com/news/white-house-pledges-3-billion-war-chest-for-covid-antivirals/
Pandemic paves way for innovative hybrid healthcareWhile the heroic abilities of the NHS have been on display throughout the COVID-19 pandemic, the last year Share XPandemic paves way for innovative hybrid healthcarehttps://pharmaphorum.com/views-and-analysis/playing-catch-up-the-evolution-of-pharma-marketing/
CureVac hit hard as its COVID jab fails to make the gradeCureVac has just had a harsh reminder of the perilous nature of drug development, after reporting that its Share XCureVac hit hard as its COVID jab fails to make the gradehttps://pharmaphorum.com/news/curevac-hit-hard-as-its-covid-jab-fails-to-make-the-grade/
